Journal of Lipid Research, Vol 35, 194-210, Copyright © 1994 by Lipid Research, Inc.

ARTICLES

Mouse apolipoprotein J: characterization of a gene implicated in atherosclerosis

TC Jordan-Starck, SD Lund, DP Witte, BJ Aronow, CA Ley, WD Stuart, DK Swertfeger, LR Clayton, SF Sells and B Paigen
Department of Pharmacology, College of Medicine, University of Cincinnati, OH 45267.

Apolipoprotein J (apoJ), a glycoprotein associated with subclasses of plasma high density lipoproteins (HDL), was found to accumulate in aortic lesions in a human subject with transplantation-associated arteriosclerosis and in mice fed a high-fat atherogenic diet. Foam cells present in mouse aortic valve lesions expressed apoJ mRNA, suggesting local synthesis contributes to apoJ's localization in atherosclerotic plaque. As a prerequisite for elucidating the physiological function of apoJ by using a mouse model, cDNA clones representing the mouse homolog of apoJ were isolated, characterized, and sequenced. The nucleotide sequence predicts a 448 amino acid, 50,260 dalton protein. There was 81% nucleotide sequence similarity between mouse and human apoJ, and 75% similarity at the amino acid level. Mouse apoJ contains six potential N-glycosylation sites, a potential Arg-Ser cleavage site to generate alpha and beta subunits, a cluster of five cysteine residues in each subunit, three putative amphipathic helices, and four potential heparin-binding domains. Southern blot analysis indicates that the gene encompasses approximately 23 kb of DNA. Recombinant inbred strains were used to map apoJ to mouse chromosome 14, tightly linked to Mtv-11. All of the transcribed portions of the gene were cloned and analyzed, and all intron-exon boundaries were defined. The first of the 9 exons is untranslated. Single exons encode the signal peptide, the cysteine-rich domain in the alpha subunit, two potential amphipathic helices flanking a heparin-binding consensus sequence, and a potential amphipathic helix overlapping a heparin-binding domain, supporting their potential functional significance in apoJ. A variety of mouse tissues constitutively express a 1.9 kb apoJ mRNA, with apparently identical transcriptional start sites utilized in all tissues tested. ApoJ mRNA was most abundant in stomach, liver, brain, and testis, with intermediate levels in heart, ovary, and kidney. The high degree of similarity between mouse and human apoJ, in structure and distribution of the gene product, gene structure, and deposition in atherosclerotic plaques, suggests that the mouse is an ideal model with which to elucidate the role of apoJ in HDL metabolism and atherogenesis.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Zenkel, F. E. Kruse, A. G. Junemann, G. O. H. Naumann, and U. Schlotzer-Schrehardt Clusterin Deficiency in Eyes with Pseudoexfoliation Syndrome May Be Implicated in the Aggregation and Deposition of Pseudoexfoliative Material Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 1982 - 1990. [Abstract] [Full Text] [PDF]

				A. L. Y. Pang, W. Johnson, N. Ravindranath, M. Dym, O. M. Rennert, and W.-Y. Chan Expression profiling of purified male germ cells: stage-specific expression patterns related to meiosis and postmeiotic development Physiol Genomics, January 12, 2006; 24(2): 75 - 85. [Abstract] [Full Text] [PDF]

				A. Chait, C. Y. Han, J. F. Oram, and J. W. Heinecke Thematic review series: The Immune System and Atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease? J. Lipid Res., March 1, 2005; 46(3): 389 - 403. [Abstract] [Full Text] [PDF]

				K. S. Leskov, D. Y. Klokov, J. Li, T. J. Kinsella, and D. A. Boothman Synthesis and Functional Analyses of Nuclear Clusterin, a Cell Death Protein J. Biol. Chem., March 21, 2003; 278(13): 11590 - 11600. [Abstract] [Full Text] [PDF]

				M. A. Deeg, R. F. Bowen, M. D. Williams, L. K. Olson, E. A. Kirk, and R. C. LeBoeuf Increased expression of GPI-specific phospholipase D in mouse models of type 1 diabetes Am J Physiol Endocrinol Metab, July 1, 2001; 281(1): E147 - E154. [Abstract] [Full Text] [PDF]

				M. A. Deeg, E. L. Bierman, and M. C. Cheung GPI-specific phospholipase D associates with an apoA-I- and apoA-IV-containing complex J. Lipid Res., March 1, 2001; 42(3): 442 - 451. [Abstract] [Full Text]

				M. G. Mahon, K. A. Lindstedt, M. Hermann, J. Nimpf, and W. J. Schneider Multiple Involvement of Clusterin in Chicken Ovarian Follicle Development. BINDING TO TWO OOCYTE-SPECIFIC MEMBERS OF THE LOW DENSITY LIPOPROTEIN RECEPTOR GENE FAMILY J. Biol. Chem., February 12, 1999; 274(7): 4036 - 4044. [Abstract] [Full Text] [PDF]

				D. J. Stone, I. Rozovsky, T. E. Morgan, C. P. Anderson, and C. E. Finch Increased Synaptic Sprouting in Response to Estrogen via an Apolipoprotein E-Dependent Mechanism: Implications for Alzheimer's Disease J. Neurosci., May 1, 1998; 18(9): 3180 - 3185. [Abstract] [Full Text] [PDF]

				Y. Ishikawa, Y. Akasaka, T. Ishii, K. Komiyama, S. Masuda, N. Asuwa, N.-H. Choi-Miura, and M. Tomita Distribution and Synthesis of Apolipoprotein J in the Atherosclerotic Aorta Arterioscler. Thromb. Vasc. Biol., April 1, 1998; 18(4): 665 - 672. [Abstract] [Full Text] [PDF]

				Q. Xu, Y. Li, C. Cyras, D. A. Sanan, and B. Cordell Isolation and Characterization of Apolipoproteins from Murine Microglia. IDENTIFICATION OF A LOW DENSITY LIPOPROTEIN-LIKE APOLIPOPROTEIN J-RICH BUT E-POOR SPHERICAL PARTICLE J. Biol. Chem., October 6, 2000; 275(41): 31770 - 31777. [Abstract] [Full Text] [PDF]